glp-1 oral medication for weight loss With FDA approval of Wegovy pill, new era of drugs begins burn more Oral GLP-1 Medication Helps Patients

Retatrutide is an investigational once-weekly injectable medication that activates three hormone receptors (GLP-1, GIP, and glucagon) to promote weight loss

It is approved for weight management in adults and pediatric patients 12 years and older with obesity, as well as adults with overweight who have at least one weight-related health condition

Inadequate protein intake is particularly concerning, as it can contribute to muscle loss during weight reduction

[16] [19] Some research suggests these anti-inflammatory effects may occur alongside weight loss, though the relative contributions of direct immunomodulation versus metabolic improvement remain unclear

[PMC free article] [PubMed] [Google Scholar] 7.Johnston IM, Nolan JD, Pattni SS, et al

The CVOT will provide definitive answers